T1	Action 15 23	targeted
T2	Concept 5 9	AIPs
R1	target Arg1:T1 Arg2:T2	
T3	Concept 0 4	Some
T4	Concept 36 41	drugs
T5	Concept 27 35	multiple
R2	in-context Arg1:T4 Arg2:T5	
R3	in-context Arg1:T2 Arg2:T3	
T6	Concept 55 106	heat shock protein 90 alpha family class A member 1
T7	Concept 108 116	HSP90AA1
*	same-as T6 T7
T8	Concept 122 143	tumor necrosis factor
T9	Concept 145 148	TNF
*	same-as T8 T9
R6	subject Arg1:T1 Arg2:T4	
T10	Concept 173 180	changes
T11	Concept 188 206	subunit structures
T12	Reference 150 155	These
T13	Concept 167 172	small
R4	has-property Arg1:T10 Arg2:T13	
R5	is-a Arg1:T12 Arg2:T10	
R7	in-place Arg1:T12 Arg2:T11	
T14	Action 207 216	translate
T15	Concept 217 221	into
R8	subject Arg1:T14 Arg2:T12	
R9	in-context Arg1:T14 Arg2:T15	
T16	Concept 229 235	shifts
T17	Concept 222 228	larger
R10	has-property Arg1:T16 Arg2:T17	
T18	Concept 243 250	hexamer
R11	in-place Arg1:T16 Arg2:T18	
R12	target Arg1:T14 Arg2:T16	
T19	Concept 266 274	patients
T20	Action 275 281	showed
T21	Concept 282 291	increased
T24	Concept 258 262	half
T25	Concept 313 322	one-third
T26	Concept 326 334	patients
T27	Action 335 343	suffered
T28	Concept 344 356	liver injury
T29	Concept 371 391	levels of prealbumin
T22	Concept 292 305	levels of LDH
R13	in-context Arg1:T19 Arg2:T24	
R14	subject Arg1:T20 Arg2:T19	
R15	has-property Arg1:T22 Arg2:T21	
R16	target Arg1:T20 Arg2:T22	
R17	in-context Arg1:T26 Arg2:T25	
T23	Concept 361 370	decreased
R18	has-property Arg1:T29 Arg2:T23	
R19	subject Arg1:T27 Arg2:T26	
R20	target Arg1:T27 Arg2:T28	
R21	target Arg1:T27 Arg2:T29	
T30	Action 478 483	lower
A1	Uncertain T30
T31	Action 557 564	prevent
A2	Negated T30
T32	Concept 466 477	effectively
R22	has-property Arg1:T30 Arg2:T32	
T33	Concept 550 556	easily
A3	Uncertain T31
R23	has-property Arg1:T31 Arg2:T33	
T34	Concept 569 578	epidemics
T35	Action 592 601	spreading
R24	target Arg1:T35 Arg2:T34	
R25	target Arg1:T31 Arg2:T35	
T36	Concept 401 408	studies
T37	Concept 392 400	Previous
R26	has-property Arg1:T36 Arg2:T37	
R27	entails Arg1:T36 Arg2:T30	
R28	entails Arg1:T36 Arg2:T31	
T38	Concept 437 455	mobility reduction
R30	subject Arg1:T30 Arg2:T38	
T40	Concept 488 502	incidence rate
R31	target Arg1:T30 Arg2:T40	
T41	Action 629 637	selected
T42	Concept 616 624	one pair
T43	Concept 611 615	only
R32	target Arg1:T41 Arg2:T42	
R33	in-context Arg1:T41 Arg2:T43	
T44	Concept 659 670	bond energy
R34	has-property Arg1:T42 Arg2:T44	
T45	Concept 682 695	2.00 kcal/mol
R35	in-context Arg1:T44 Arg2:T45	
T39	Concept 513 529;534 543	transmissibility reduction
T46	Concept 509 512	50%
R29	in-context Arg1:T39 Arg2:T46	
R36	subject Arg1:T31 Arg2:T39	
R37	subject Arg1:T1 Arg2:T6	
R38	subject Arg1:T1 Arg2:T8	
R39	is-a Arg1:T6 Arg2:T4	
R40	is-a Arg1:T8 Arg2:T4	
